Navigation Links
Zafgen Announces Initiation of Phase 2a Clinical Development with Beloranib in Obesity
Date:11/6/2012

CAMBRIDGE, Mass., Nov. 6, 2012 /PRNewswire/ -- Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced that it has initiated Phase 2a clinical testing of  beloranib.  This milestone follows the completion of three consecutive Phase 1b studies demonstrating rapid weight loss, reductions in body fat, improvements in cardiovascular risk factors and encouraging tolerability.

Beloranib, a novel therapy for obesity that utilizes a unique mechanism of action targeting methionine aminopeptidase 2 (MetAP2), is in development to assess its potential to safely and rapidly reduce body weight by restoring balance between the production and utilization of fat.

"This transition to larger and longer clinical trials is a significant milestone for Zafgen and for patients who suffer from severe obesity," Thomas Hughes, Ph.D., president and CEO of Zafgen, said.  "We are looking forward to learning more about the safety and efficacy of treatment with beloranib over a longer period of time.  Given the consistent and rapid weight loss we have observed with beloranib in previous studies, there appears to be significant potential to help severely obese patients, whose options are currently limited, to achieve a healthier weight and improve risk factors associated with type 2 diabetes and cardiovascular disease."

The first Phase 2a clinical trial will evaluate weight loss, safety and pharmacokinetics of beloranib administered twice a week.  Obese men and women with and without type 2 diabetes will receive subcutaneous injections for 12 weeks at eight participating centers.  The trial design is a randomized, double-blind, placebo-controlled study evaluating a range of doses in approximately 150 patients.

"Early results from clinical trials studying beloranib's effects on body weight and cardiovascular risk markers in obese patients have been very encourag
'/>"/>

SOURCE Zafgen, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Rigel Announces Third Quarter 2012 Financial Results
2. Jazz Pharmaceuticals Announces Support for National Campaign Designed to Curb Prescription Drug Abuse
3. Mindray Medical Announces Top Management Change
4. Cepheid Announces Executive Vice President Emerging Markets
5. Cardica Announces Fiscal 2013 First Quarter Financial Results
6. PDL BioPharma Announces Third Quarter 2012 Financial Results
7. DURECT Corporation Announces Third Quarter 2012 Financial Results and Update of Programs
8. Global Green, Inc. Announces DTC Eligibility
9. Psychemedics Corporation Announces 3rd Quarter Earnings
10. Medisafe 1 Technologies Announces Delay in Closing $7MM Perpetual License Sale Due to Hurricane Sandy
11. Life Sciences Entrepreneurs S.L.U. Announces the First Financing of the Antiplatelet Candidate NmC by Spanish and Swiss Investors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... -- The Galien Foundation today announced the 2014 nominees ... Awards. The Prix Galien Award is considered ... scientific and clinical research skills necessary to develop innovative ... highest number of nominees since the inception of the ... biomedical products across three categories – biotechnology, pharmaceutical, and ...
(Date:7/31/2014)... und KISSING, Deutschland, 31. Juli ... und Distributor eines computerunterstützten („robotischen") Koloskopie-Systems für ... (Homi) Shamir , ein weltweit anerkannter Manager ... und Kontrollgremiums zum Unternehmen stößt. ... Shamir ist ein hochangesehener globaler Visionär ...
(Date:7/31/2014)... WASHINGTON , July 31, 2014 ... is the first pharmacy in the nation to ... the leading health care accreditation organization that establishes ... CVS/pharmacy and Longs Drug Store locations nationwide have ... over 30 accreditation programs. Its Community Pharmacy Accreditation ...
Breaking Medicine Technology:The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 4The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 5invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 3CVS/pharmacy Earns First-Ever Community Pharmacy Accreditation from URAC 2CVS/pharmacy Earns First-Ever Community Pharmacy Accreditation from URAC 3
(Date:7/31/2014)... HealthDay Reporter THURSDAY, July 31, 2014 (HealthDay ... has shown an increased risk of spreading undetected cancers in ... market. In a letter that was to be sent ... that its laparoscopic power morcellators be returned to the company, ... of new morcellators had been suspended in April after the ...
(Date:7/31/2014)... Atlanta-based Jvion, a leader in clinical ... lessons in predictive population health analytics as part of ... analytics in healthcare. Ritesh Sharma, Jvion COO, commented, “it ... to understand the impact of and potential within predictive ... and a good portion of it is conflicting or ...
(Date:7/31/2014)... 31, 2014 The rising population of ... driving the global geriatric care services market wherein a ... of these services across the globe. There are service ... care agency to few large companies with national and ... underserved and is also highly fragmented. The developed nations ...
(Date:7/31/2014)... of 1944, the Nazis blocked food supplies to the ... devastation. The impact of starvation on expectant mothers produced ... resulting from external rather than genetic influences which ... be inherited. The underlying mechanism, however, remained a mystery. ... journal Cell , Dr. Oded Rechavi, Dr. Leah ...
(Date:7/31/2014)... The “Nucleic Acid Isolation and ... Magnetic bead based), Consumables & Instruments, by Application ... End users - Global Forecasts to 2018” provides ... challenges, opportunities, current market trends, and strategies impacting ... along with the estimates and forecasts of the ...
Breaking Medicine News(10 mins):Health News:J&J Pulls Hysterectomy Tool Tied to Cancer Risk From Market 2Health News:J&J Pulls Hysterectomy Tool Tied to Cancer Risk From Market 3Health News:Jvion Releases Top Three Lessons in Predictive Population Health Analytics 2Health News:Jvion Releases Top Three Lessons in Predictive Population Health Analytics 3Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 2Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 3Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 4Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 5Health News:The 'memory' of starvation is in your genes 2Health News:The 'memory' of starvation is in your genes 3Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 4
... the billions of pounds being spent on hospitals for the NHS ... of care.// ,The report has claimed that the NHS ... 30 years to pay off, when the present plans for the ... people live. ,According to this report the Department of ...
... have suggested that some links exist between Alzheimer's and Type ... two are actually// different forms of the same disease. ... causes to the pancreas is similar to the effect of ... on Saturday during the International Conference on Alzheimer's Disease and ...
... the lowest number of reported HIV/Aids cases in the world ... prove it.// ,This was the conclusion of the ... Ministry of Health. Neighboring countries have also reported a similar ... behavioral norms have contributed to keeping infection at very low ...
... sleep-deprived youth working continuously on night shifts in BPO ... night, skipping breakfast, eating lunch in the evening and ... Lim Li Ling, Deputy Director, sleep disorders unit, Singapore ... would be affected due to lack of proper sleep, ...
... Indian Ocean such as Mauritius have been struck by a ... far, according to doctors. // ,The chikungunya virus ... and rashes and is potentially lethal. It has ravaged the ... Researchers from the University of Lausanne, Switzerland have reported the ...
... U.S. are suffering from long-term spinal cord injuries, with more ... ,One study appearing in the July 12th issue of the ... towards providing evidence that a combination of treatments could lead ... The result would be a return of functional activity. ...
Cached Medicine News:Health News:Diabetes and Alzheimer's disease May be Two Sides of the Same Coin 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: